Ganglioside GM3 inhibits growth of several cancer cells and induces cell cycle arrest by regulating cellular signal pathways. Our previous results have shown that GM3 suppresses tumor suppressor PTEN-mediated cancer cell proliferation. However, the precise molecular mechanism(s) 
Introduction
Glycosphingolipids (GSLs) are ubiquitous components of plasma membrane in all mammalian cells, and they are concentrated in specialized microdomains for cell signaling (Hakomori, S. 2000) .
Gangliosides, GSLs with sugar chains containing sialic acid, have been implicated in fundamental cell processes such as proliferation, differentiation, adhesion and signal transduction (Birkle, S., Zeng, G., et al. 2003 , Hakomori, S. 1990 , Svennerholm, L. 1980 , Varki, A. 1993 . Specifically, gangliosides are 4 degrading tumor suppressor p53 protein through PI-3K/AKT-mediated MDM2 phosphorylation (Choi, H.J., Chung, T.W., et al. 2006 , Mayo, L.D., Dixon, J.E., et al. 2002 . Recent studies have shown that the frequent inactivation of PTEN is due to hypermethylation of promoter in a variety of tumor cells, leading to inhibition of PTEN gene expression (Goel, A., Arnold, C.N., et al. 2004 , Schondorf, T., Ebert, M.P., et al. 2004 . Although PTEN significantly functions in survival or apoptosis of cancer, very little is known about the regulation of PTEN gene expression in response to numerous apoptotic stimuli (Stambolic, V., MacPherson, D., et al. 2001 , Vasudevan, K.M., Gurumurthy, S., et al. 2004 , Virolle, T., Adamson, E.D., et al. 2001 .
Activator protein 2 is a sequence-specific DNA-binding transcription factor that is known to regulate either activating or repressing effect on target gene by directly or indirectly (Bosher, J.M., Williams, T., et al. 1995 , Gille, J., Swerlick, R.A., et al. 1997 , Hennig, G., Lowrick, O., et al. 1996 , Mitchell, P.J., Wang, C., et al. 1987 , Zutter, M.M., Santoro, S.A., et al. 1994 . The protein consists of five homologous members including AP-2α, AP-2β, AP-2γ, AP-2δ and AP-2ε (Bosher, J.M., Totty, N.F., et al. 1996 , Moser, M., Imhof, A., et al. 1995 , Tummala, R., Romano, R.A., et al. 2003 , Williams, T., Admon, A., et al. 1988 , Zhao, F., Satoda, M., et al. 2001 . Each of the proteins is encoded by separate gene and their expression is cell-type specific. AP-2 homo-and heterodimers can activate transcription with a core recognition element sequence of 5'-GCCNNNGGC-3'. Among others, AP-2α plays an important role as regulator of gene expression during vertebrate development, embryogenesis and transformation (Schorle, H., Meier, P., et al. 1996 , Somasundaram, K., Jayaraman, G., et al. 1996 , Zeng, Y.X., Somasundaram, K., et al. 1997 , Zhang, J., Hagopian-Donaldson, S., et al. 1996 . Recently, several literatures elucidate that, in a various cancer, loss or reduced expression of AP-2α has been associated with cancer progression, indicating as a tumor suppressor gene (Bar-Eli, M. 1999 , Heimberger, A.B., McGary, E.C., et al. 2005 , Schwartz, B., Melnikova, V.O., et al. 2007 ). In addition, dominant negative mutant of AP-2α is found to expand tumor growth and metastasis in human melanoma cells (Bar-Eli, M. 2001 , Gershenwald, J.E., Sumner, W., et al. 2001 . Inversely, overexpression of AP-2α has been shown to suppress invasion of ovarian cancer cells as well as mammary gland growth and morphogenesis (Sumigama, S., Ito, T., et al. 2004, Zhang, J., Brewer, S., at Pennsylvania State University on February 23, 2013 http://glycob.oxfordjournals.org/ Downloaded from 5 et al. 2003) . Similarly, in vivo studies involving colon carcinoma have reported a decrease in AP-2α expression levels in Dukes's stage adenocarcinomas (Ropponen, K.M., Kellokoski, J.K., et al. 2001) .
Recently, we have been reported that GM3 had an effect on the expression of tumor suppressor PTEN resulting in cell cycle arrest through up-regulation of p21 WAF1 and p27 kip1 in colon cancer cells (Choi, H.J., Chung, T.W., et al. 2006) . However, the precise molecular mechanism for transcriptional regulation of PTEN gene induced by GM3 in colon cancer cells remains unclear. In this study, we functionally characterized the ability of the PTEN promoter region to direct up-regulation of reporter gene transcription in response to GM3. The present results, for the first time, suggest that the AP-2 binding site of the PTEN promoter plays an important role in transcriptional regulation of the PTEN gene by GM3. In addition, the transcription factor AP-2α has an effect on the up-expression of PTEN gene in GM3-stimulated colorectal cancer cells.
Materials and Methods

Cell line and Cell culture
Human colon cancer cell lines HCT116, HCT116 p53(-/-) and RKO were cultured in Dulbecco's modified Eagle's medium (DMEM; JBI, Daegu, Korea) supplemented with 10% fetal bovine serum, 100 unit/ml penicillin and 100 μg/ml streptomycin at 37°C under 5% CO 2 . Human colon cancer SW480 cells and HT29 cells were maintained in RPMI 1640 medium (JBI) supplemented with 10% fetal bovine serum.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA from each cell was isolated using the Trizol reagent (JBI), and two micrograms of RNA was subjected to reverse transcription with oligo dT primer using AccuPower® RT-PreMix (antisense). The use of equal amounts of mRNA in the RT-PCR assay was confirmed by analyzing the expression levels of β-actin. The PCR products were separated by gel electrophoresis on 1.5%
agarose-containing ethidium bromide with 0.5× Tris-acetate-EDTA (TAE) buffer. After electrophoresis, the intensity of the bands obtained from RT-PCR result was estimated using TotalLab software of Frog Gel Image Analysis System (CorebioSystem, Seoul, Korea).
Western blot analysis
Cells were homogenized in a buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.02% NaN 3 , 100 μg/ml phenylmethylsulfonyl fluoride (PMSF), 1 μg/ml aprotinin and 1% Triton X-100.
Protein concentrations were measured using the Bio-Rad protein assay (Bio-Rad, Richmond, CA).
Thirty-microgram samples of total cell lysates were size fractionated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and electrophoretically transferred to nitrocellulose membranes using the Hoefer electrotransfer system (Amersham Biosciences, Buckinghamshire, UK).
To detect target protein, we incubated the membranes with the PTEN (NeoMarker, Fremont, CA), AP-2α (Santa Cruz Biotechnology, CA), glyceraldehydes-3-phosphode-hydrogenase (GAPDH) (Chemicon, Temecula, CA), VEGFR-2 (Santa Cruz Biotechnology), p-VEGFR-2 (Cell Signaling, MA), EGFR (Santa Cruz Biotechnology) and p-EGFR (Santa Cruz Biotechnology) antibodies, respectively. Detection was performed using a secondary horseradish peroxidase-linked anti-mouse antibody and an anti-rabbit antibody, and ECL chemiluminescence system (Amersham Biosciences).
After western blotting, the intensity of the bands obtained from film result was estimated using TotalLab software of Frog Gel Image Analysis System (CorebioSystem, Seoul, Korea).
at Pennsylvania State University on February 23, 2013 http://glycob.oxfordjournals.org/
Downloaded from
Preparation of plasmids and mutagenesis
For the reporter analysis of the PTEN promoter, pro1517, pro621, pro448 and pro65 were prepared the plasmids constructed previously (Chung, T.W., Lee, Y.C., et al. 2003 
Transfection and luciferase assay
Cells were plated onto 6-well plates at density of 10 5 cells/well and grown overnight. Cells were co-transfected with 0.5 pmol of PTEN promoter-luciferase reporter constructs and 0.5 μg of β-galactosidase reporter plasmid by WelFect-EX TM PLUS method (JBI). Cells were cultured in medium containing 10% FBS and incubated with GM3 (Alexsis, CA) for 24 h. Luciferase activity and β-galactosidase activity were assayed by using the luciferase and β-galactosidase enzyme assay system (Promega). Luciferase activity was normalized with the β-galactosidase activity in the cell lysate and calculated as an average of three independent experiments.
Electrophoretic mobility shift assays (EMSA)
Nuclear extracts from resting and GM3-induced HCT116 cell were prepared as described previously (Chung, T.W., Lee, Y.C., et al. 2003) . EMSAs were performed using gel shift assay system kit (Promega) according to the manufacturer's instructions. Briefly, double-stranded oligonucleotides containing the consensus sequence for AP2-1 (5'-CCGAGCAAGCCCCAGGCAGCTACAC-3') and AP2-2 (5'-CTCAGTAGAGCCTGCGGCTTGGGGACT-3') were end-labeled with [γ-32 P]ATP using T4 polynucleotide kinase and used as probes for EMSA. Nuclear extract proteins (2 μg) were preincubated with the gel shift binding buffer [4% glycerol, 1 mM MgCl 2 , 0.5 mM ethylenediamine tetra-acetic acid, 0.5 mM dithiothreitol, 50 mM NaCl, 10 mM Tris-HCl (pH 7.5) and 0.05 mg/ml poly (deoxyinosine-deoxycytosine)] for 10 min and then incubated with the labeled probe for 20 min at room temperature. For the sample of supershift assay, anti-AP-2α, -SP1, -SP3, -Ets-1, and p53
antibodies were preincubated with nuclear extract prior to addition of labeled probes. Each sample was electrophoresed in a 4% nondenaturing polyacrylamide gel in 0.5× TBE buffer at 250 V for 2 h.
The resulting gel was dried and subjected to autoradiography.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed as outlined by the ChIP assay kit ( 
Preparation and transfection of small interference RNAs ( siRNAs)
AccuTarget TM siRNA Set targeting TFAP2A (AP-2α) was purchased from Bioneer Corporation.
The coding sequence of plant chlorophyll a/b-binding protein mRNA of siRNA duplex was synthesized as negative control by Bioneer Corporation. HCT116 cells were transfected with AP-2α siRNA and negative control siRNA respectively using WelFect-EX TM PLUS (JBI), according to the manufacturer's instructions. One day after transfection, transfection complexes were removed and replaced with culture medium. After incubating with GM3 in culture medium for 12 h, the transfected cells were used for experiments.
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Results
GM3 promotes the expression of PTEN gene.
To determine whether GM3 has the ability to regulate the expression of PTEN gene, HCT116
colon cancer cells were exposed to various concentrations (0, 10, 30, 50 μM) of GM3, and were incubated for 0, 12 or 24 h after the treatment of 30 μM GM3. As shown in Figure 1A , the mRNA expression of PTEN gene was increased gradually up to concentration of 50 μM, and also increased demonstrated that the transcriptional activation of PTEN gene was regulated by a transcription factor p53 (Stambolic, V., MacPherson, D., et al. 2001 ). Thus, we also investigated whether GM3 regulates the p53-mediated PTEN transcription using HCT116 cells lacking p53. However, as shown in Figure   1C , although the regulation of PTEN transcription by p53 protein was known, GM3 in p53-negative HCT116 cells had effect on the increase of PTEN expression as evidenced by RT-PCR and western blot analysis. These results indicate that enhanced PTEN expression by GM3 is not accompanied by regulation of p53.
Localization of the GM3-dependent positive element in the human PTEN promoter
To further confirm the region regulating the transcription activity of PTEN gene in GM3-induced HCT116 cells, a genomic fragment containing 1517 bp of 5'-promoter region of PTEN gene was subcloned into pGL3-basic vector (pro1517). The luciferase constructs carrying 5'-deleted PTEN gene promoter (pro1253, pro847 and pro454 constructed from translation initiation site and pro621, pro448, pro357, pro279, pro181 and pro65 constructed from transcriptional start site) were also prepared ( 2 ) clearly showed that GM3 induced p53-independent PTEN expression. Thus, we suggest that GM3 may regulate AP-2-mediated the transcriptional activation of PTEN gene.
The AP-2α is essential for the transcriptional regulation of PTEN gene in response to GM3
Our previous study has determined that GM3 induces PTEN expression through p53-independent mechanism. Virolle et al. has reported that the EGR-1 transcription factor directly activates PTEN during irradiation (Virolle, T., Adamson, E.D., et al. 2001 ). However, GM3 had no effect on the luciferase activity of pro65 which contains region between -962 and -897 from translation initiation site of PTEN gene and two EGR-1 binding site (Figure 2 ). Additionally, Vasudevan et al. has demonstrated that NF-кB negatively regulates tumor suppressor PTEN expression (Vasudevan, K.M., Gurumurthy, S., et al. 2004 ). Thus, we examined whether GM3 modulates PTEN expression by NF-кB down-regulation. However, the expression of p65 protein, a subunit of heterodimeric NF-кB transcription activator, was not down-regulated by GM3 in HCT116 colon cancer cells. Furthermore, EMSA data showed that the intensity levels of the p65-shift bands in the nuclear lysates from GM3-induced HCT116 cells were unchanged compared to GM3-untreated HCT116 cells (data not shown).
Therefore, we assumed that the transcriptional activity of PTEN could be regulated by GM3 through the two AP-2 binding site. To evidence that the PTEN expression by GM3 is related to AP-2α
at Pennsylvania State University on February 23, 2013 http://glycob.oxfordjournals.org/ Downloaded from transcription factor, we investigated the effect of GM3 on the expression of AP-2α. Interestingly, as shown in Figure 3A , the transcription of AP-2α was significantly increased in GM3-treated HCT116 cells as evidenced by RT-PCR. Western blot analysis also showed the gradual increase of AP-2α expression for periods of up to 24 h in nuclear extract of GM3-treated HCT116 cells ( Figure 3B ). To determine whether the AP-2 binding site is associated with the regulation of PTEN transcription in HCT116 cells induced by GM3, we performed EMSA using double-stranded 32 P-labeled oligo fragments containing the consensus sequence for two specific AP2-1 and AP2-2 of PTEN promoter and nuclear extract from GM3-treated HCT116 cells. As shown in Figure 3C , a complex that binds to 32 P-labeled AP2-1 and AP2-2 oligo nucleotides was detected and the intensity levels of the AP-2-shifted bands in the nuclear lysates from GM3-induced HCT116 cells were higher than the nuclear lysates from GM3-uninduced HCT116 cells. These bindings were competed with a 100-fold molar excess of unlabeled AP2-1 and AP2-2 oligo fragments itself. To further clarify whether this band of DNA-protein complex containing two AP-2 oligo nucleotides (AP2-1 and AP2-2) could be associated with AP-2α protein, we performed supershift assay in presence of anti-AP-2α antibody. As shown in Figure 3C , the incubation of nuclear extracts with anti-AP-2α antibody resulted in a supershift of the observed complexes. Addition of anti-Ets-1, p53, SP1 and SP3 antibodies did not produce a supershifted complex but anti-SP1 antibody did reduce the intensity of the shifted complex in extracts from the GM3-treared HCT116 cells. To better understand the interplay between AP-2 and SP1 family members in the regulation of the PTEN promoter in vivo, we analyzed a 299 bp fragment that spans the -1268 to -970 regions using a chromatin immunoprecipitation assay ( Figure 3D ). Interestingly, in the GM3-stimulated HCT116 cells, AP-2α was bound to the distinguished activity region of PTEN promoter but not SP1. Although our gel shift data showed that AP-2 weakly bound to the -279 to -182 region in vitro, it clearly certified to its binding in vivo. In p53-negative HCT116 cells induced by GM3, we obtained the same results using western blot and EMSA analysis like GM3-stimulated HCT116 cells ( Figure 3E and 3F). To additionally confirm that GM3 is directly involved in AP-2α-mediated transcriptional activation of PTEN, AP2-1 Mu, AP2-2 Mu and AP-2 double Mu were constructed by mutating AP-2 binding sites from pro279 plasmid using site-directed mutagenesis kit at Pennsylvania State University on February 23, 2013 http://glycob.oxfordjournals.org/ Downloaded from 13 ( Figure 4A ). As shown in Figure 4B , in GM3-treated HCT116 cells, the promoter activity of pro279 including two AP-2 binding sites was remarkably increased compared to control vector pGL3-Basic.
However, promoter activity of both AP2-1 Mu and AP2-2 Mu, which were mutated at -1109 to -1101
and -1143 to -1135 of PTEN promoter region respectively, was significantly reduced compared to pro279 in response to GM3. Furthermore, the promoter activity of AP-2 double Mu which was mutated at both AP2-1 and AP2-2 binding sites markedly reduced compared to pro279 in GM3-treated HCT116 cells. These results clearly show that AP-2 binding sites are required for the GM3-induced expression of PTEN, and that the AP-2α binding to these sites involved in the induction of PTEN by GM3.
Transcription factor AP-2α enhances PTEN expression
Preferentially, our data showed that the expression of AP-2α in AP-2α-positive Hela, AP-2α-negative SW480 and HCT116 colon cancer cells were verified by western blot analysis in the cytosol and nuclear extractions ( Figure 5A ). To further confirm AP-2α function, we investigated whether promoter activity of pro279 reporter in AP-2α-transfected SW480 cells was increased 2-fold higher than that of the pcDNA3-transfected SW480 cells ( Figure 5C ). These results demonstrate for the first time that transcription factor AP-2α is associated with PTEN expression.
siRNA targeting AP-2α gene reduces the expression of PTEN gene induced by GM3
To confirm whether the suppression of AP-2α level by RNA interference in GM3-treated cells results in the reduction of PTEN expression, three siRNAs (siRNA 1, siRNA 2 and siRNA 3) against AP-2α and a siRNA as a negative control were utilized to the HCT116 colon cancer cells. As shown in Figure 6A 
Inhibition of EGFR activation by GM3 raises the level of AP-2α protein
We explore what is upstream signaling pathway regulating AP-2α signaling. It is well known that GM3 inhibits EGFR tyrosine kinase (Hanai, N. Figure 7A , auto-activation of EGFR in HCT116 cells was inhibited by GM3. Furthermore, as described in the Figure 1 and 3, our previous data have clearly shown that GM3 induces both expression of AP-2α and PTEN. To further confirm whether EGFR activation leads to regulation of AP-2α and PTEN expression, we treated HCT116 cells with AG1478 known a specific inhibitor of EGFR tyrosine kinase in HCT116 cells. As shown in Figure 7B , Figure 7C ), VEGFR-2 inhibitor I (Calbiochem, CA) has no effect on AP-2α and PTEN expressions ( Figure 7D ). These results suggest that GM3 do not affect AP-2α-mediated PTEN regulation through VEGFR-2 signaling pathway. These results suggest that GM3 increases AP-2α expression through the suppression of autocrine ligand-mediated EGFR activation in HCT116 cells.
Discussion
The PTEN gene has been shown to be deleted or mutated in many human cancers including endometrial neoplasm, hematological malignancies, prostate, breast and other cancer types ( negatively controls the PI-3K signaling pathway for regulation of cell growth and survival (Stambolic, V., Suzuki, A., et al. 1998 , Sun, H., Lesche, R., et al. 1999 show that PTEN expression by GM3 also was increased in p53-null HCT116 cells. These data suggest that GM3 regulate p53-independent PTEN transcription in colon cancer cells.
Our results in this study show that the region between -1175 and -1077 of the PTEN promoter The lipid moiety of the exogenous gangliosides mostly appears to be inserted into lipid bilayer of plasma membrane (Callies, R., Schwarzmann, G., et al. 1977 , Radsak, K., Schwarzmann, G., et al. 1982 . Our previously result show that GM3 is localized on the surface of membrane (Choi, H.J., Chung, T.W., et al. 2006) . For this reason, GM3 has been implicated in a variety of cell-surface events such as recognition phenomena and membrane-mediated signaling transduction (Fishman, P.H. and Brady, R.O. 1976 , Hakomori, S. 1981 , Hakomori, S. 1990 , Laine, R.A. and Hakomori, S. 1973 .
Exogenously treated GM3 is rapidly incorporated into plasma membrane and is responsible for numerous biological effects in vitro (Choi, H.J., Chung, T.W., et al. 2006, Laine, R.A. and Hakomori, S. 1973) . For example, the EGF-mediated proliferation of epidermal cells is inhibited by GM3 interaction with N-linked GlcNAc termini of receptor (Yoon, S.J., Nakayama, K., et al. 2006) . GM3 also suppresses the PDGF-and basic fibroblast growth factor (bFGF)-mediated proliferation of fibroblast cells and neuroblastoma cells for blocking receptor dimerization (Rusnati, M., Tanghetti, E., et al. 1999 , Van Brocklyn, J., Bremer, E.G., et al. 1993 . Based on these studies, we hypothesized that the suppression of receptor activity on cell membrane associated with the proliferation of colon cancer receptor (VEGFR) expressed in endothelial cell (Ferrara, N. 2004 , Ferrara, N., Gerber, H.P., et al. 2003 . Furthermore, VEGF and VEGFR expression in several human tumors stimulates tumor survival and proliferation through autocrine pathway (Masood, R., Cai, J., et al. 2001) . Thus, we investigated whether inactivation of VEGFR by GM3 modulates AP-2α and PTEN expression in HCT116 cells having VEGF and VEGFR expression. However, our results indicated that GM3 does not affect AP-2α-mediated PTEN regulation through VEGFR-2 signaling pathway. Whereas, it is well known that GM3 inhibits EGFR tyrosine kinase (Hanai, N., Nores, G.A., et al. 1988 , Wang, X.Q., Sun, P., et al. 2003 , Yoon, S.J., Nakayama, K., et al. 2006 . Brattain group has shown that autocrine TGF-α as a member of EGF family in the highly tumorigenic HCT116 cells induces activation of EGFR associated with cell growth via interaction with EGFR (Howell, G.M., Humphrey, L.E., et al. 1998 ).
Thus, we examined whether GM3 suppresses EGFR activation in HCT116 colon cancer cells. This study showed that auto-activation of EGFR in HCT116 cells was inhibited by GM3. Furthermore, we further investigated whether EGFR activation has an effect on AP-2α and PTEN expression. The treatment of HCT116 cells with AG1478 known as an inhibitor of EGFR tyrosine kinase activity resulted in the induction of AP-2α and PTEN expression. Taken together, GM3 increases AP-2α expression through the suppression of autocrine ligand-mediated EGFR activation in HCT116 cells.
In conclusion, as illustrated in Fig. 8 , we demonstrate for the first time that the simple ganglioside GM3 modulates AP-2α expression through EGFR pathway and the AP-2α is essential for the transcriptional regulation of PTEN gene in response to GM3 for the suppression of cell proliferation and cell cycle arrest. GAPDH and hnRNP1 were included as internal control. 
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